Literature DB >> 24591872

The combination of letrozole and melatonin causes regression in size not histopathological scores on endometriosis in an experimental rat model.

Gazi Yıldırım1, Rukset Attar1, Cem Fıçıcıoğlu2, Ateş Karateke1, Ferda Ozkan3, Ertuğrul Kılıç4, Bayram Yılmaz5, Narter Yeşildağlar1.   

Abstract

OBJECTIVE: To determine the effects of the combination of letrozole and melatonin on surgically induced endometriosis.
MATERIAL AND METHODS: This prospective, randomized, controlled, experimental study was carried out at Yeditepe University Experimental Research Center (YUDETAM). Female non-pregnant, 17 nulligravid Wistar - Hannover albino rats with surgically induced endometriosis were used in this study. Endometriosis was induced by using homologous uterine horn transplantation in the rats. Four operations were performed on each rat. The induction of endometriosis was performed in the first operation. After two weeks of estradiol treatment the second operation was performed and endometriotic lesions were evaluated. Estrogen was then discontinued and in the study groups medications were started. During two weeks the rats were given medications and the third operation was performed for the assessment of the effects of the medications on the endometriotic foci. Then all the medications were stopped and estrogen was started again. Two weeks later all the rats were euthanized and recurrence of endometriosis was evaluated.
RESULTS: The sum of the lesion volumes in the control group was 93.6±31.7 mm(3) at the end of the second week. After the cessation of estradiol it decreased to 85.0±23.8 mm(3) (P=0.31) and increased to 119.7±29.4 mm(3) at the sixth week (P=0.02). A significant reduction in histopathologic scores were seen after cessation of the estradiol (p=0.04). At the end of the sixth week, histopathological scores reached the pretreatment values. In the letrozole and melatonin group the sum of the lesion volumes decreased significantly after the treatment (82.8±21.0 mm(3) and 15.7±8.0 mm(3) respectively). At the end of the sixth week, the mean volume was calculated as 43.9±31.8 mm(3) (p=0.002). Histopathologic scores were 2.3±0.1, 2.0±0.2 and 2.2±0.3 at the end of the second, fourth and sixth weeks, respectively, in the letrozole and melatonin group.
CONCLUSIONS: Letrozole and melatonin caused a significant regression in lesion volumes; however, histopathological scores of endometriotic lesions did not change significantly.

Entities:  

Keywords:  Endometriosis; letrozole; melatonin; rat endometriosis

Year:  2009        PMID: 24591872      PMCID: PMC3939165     

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  20 in total

1.  Melatonin as an antioxidant: physiology versus pharmacology.

Authors:  Russel J Reiter; Dun-Xian Tan; Maria D Maldonado
Journal:  J Pineal Res       Date:  2005-09       Impact factor: 13.007

2.  Anastrazole and oral contraceptives: a novel treatment for endometriosis.

Authors:  Lisa L Amsterdam; William Gentry; Smeta Jobanputra; Michael Wolf; Stephen D Rubin; Serdar E Bulun
Journal:  Fertil Steril       Date:  2005-08       Impact factor: 7.329

Review 3.  Oxidative stress and peritoneal endometriosis.

Authors:  Anne Van Langendonckt; Françoise Casanas-Roux; Jacques Donnez
Journal:  Fertil Steril       Date:  2002-05       Impact factor: 7.329

Review 4.  Role of oxidative stress in endometriosis.

Authors:  Sajal Gupta; Ashok Agarwal; Natalie Krajcir; Juan G Alvarez
Journal:  Reprod Biomed Online       Date:  2006-07       Impact factor: 3.828

5.  Immunohistochemical assessment of superoxide dismutase expression in the endometrium in endometriosis and adenomyosis.

Authors:  H Ota; S Igarashi; J Hatazawa; T Tanaka
Journal:  Fertil Steril       Date:  1999-07       Impact factor: 7.329

6.  Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole.

Authors:  J A Keenan; P K Williams-Boyce; P J Massey; T T Chen; M R Caudle; A Bukovsky
Journal:  Fertil Steril       Date:  1999-07       Impact factor: 7.329

Review 7.  Actions of melatonin in the reduction of oxidative stress. A review.

Authors:  R J Reiter; D X Tan; C Osuna; E Gitto
Journal:  J Biomed Sci       Date:  2000 Nov-Dec       Impact factor: 8.410

8.  Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial.

Authors:  J Balasch; M Creus; F Fábregues; F Carmona; S Martínez-Román; D Manau; J A Vanrell
Journal:  Hum Reprod       Date:  1997-09       Impact factor: 6.918

9.  Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.

Authors:  Radhika K Ailawadi; Smeeta Jobanputra; Meera Kataria; Bilgin Gurates; Serdar E Bulun
Journal:  Fertil Steril       Date:  2004-02       Impact factor: 7.329

10.  Regression of endometrial explants in a rat model of endometriosis treated with melatonin.

Authors:  Mehmet Güney; Baha Oral; Nermin Karahan; Tamer Mungan
Journal:  Fertil Steril       Date:  2007-06-19       Impact factor: 7.329

View more
  2 in total

Review 1.  Melatonin in Endometriosis: Mechanistic Understanding and Clinical Insight.

Authors:  Yiran Li; Sze-Wan Hung; Ruizhe Zhang; Gene Chi-Wai Man; Tao Zhang; Jacqueline Pui-Wah Chung; Lanlan Fang; Chi-Chiu Wang
Journal:  Nutrients       Date:  2022-10-01       Impact factor: 6.706

2.  Melatonin inhibits 17β-estradiol-induced migration, invasion and epithelial-mesenchymal transition in normal and endometriotic endometrial epithelial cells.

Authors:  Shasha Qi; Lei Yan; Zhao Liu; Yu-Lan Mu; Mingjiang Li; Xingbo Zhao; Zi-Jiang Chen; Hui Zhang
Journal:  Reprod Biol Endocrinol       Date:  2018-06-23       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.